Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 3718910)

Published in World J Gastroenterol on July 21, 2013

Authors

Jian-Yong Lei1, Lu-Nan Yan, Wen-Tao Wang

Author Affiliations

1: Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, Sichuan Province, China.

Articles cited by this

Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22

Management of hepatocellular carcinoma. Hepatology (2005) 27.42

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14

Hepatocellular carcinoma: A global view. Nat Rev Gastroenterol Hepatol (2010) 5.87

A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg (2010) 4.75

Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology (2008) 4.26

Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg (1991) 3.57

Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg (2002) 3.52

A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant (2009) 3.09

The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis (2010) 2.96

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl (2010) 2.57

Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg (2009) 2.30

Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg (1997) 2.28

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl (2002) 2.28

Epidemiology of hepatocellular carcinoma. Clin Liver Dis (2001) 2.06

Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant (2008) 2.06

Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl (2005) 2.04

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg (1998) 1.90

Hepatocellular carcinoma: therapy and prevention. World J Gastroenterol (2005) 1.87

Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg (1998) 1.61

Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinoma. Cancer (2010) 1.48

Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol (1997) 1.45

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data. Liver Transpl (2009) 1.31

Sociodemographic differences in early access to liver transplantation services. Am J Transplant (2009) 1.30

Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant (2008) 1.27

Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl (2003) 1.24

Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. J Surg Oncol (2010) 1.21

alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology (2002) 1.16

Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterology (1998) 1.14

Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation. Am J Transplant (2009) 1.11

An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann Surg Oncol (2007) 1.11

Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft. Transplantation (2009) 1.10

De novo malignancies following liver transplantation: impact and recommendations. Liver Transpl (2009) 1.09

Management of early hepatocellular carcinoma in patients with well-compensated cirrhosis. Ann Surg Oncol (2009) 1.07

Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin. Am J Transplant (2010) 1.05

Outcomes after liver transplantation: chronic kidney disease. Liver Transpl (2009) 1.05

Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg (2008) 1.04

HCC: current surgical treatment concepts. Langenbecks Arch Surg (2012) 1.03

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg (1999) 1.02

Serum alphafetoprotein in hepatocellular carcinoma. Cancer (1977) 0.96

Recurrence after resection of alpha-fetoprotein-positive hepatocellular carcinoma. J Cancer Res Clin Oncol (1994) 0.96

Surgical treatment for early hepatocellular carcinoma: comparison of resection and liver transplantation. J Cancer Res Clin Oncol (2010) 0.92

Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma. J Surg Oncol (2007) 0.90

Resection and liver transplantation for HCC. J Gastroenterol (2009) 0.90

The value of serum alpha-fetoprotein in predicting tumor recurrence after liver transplantation for hepatocellular carcinoma. Dig Dis Sci (2008) 0.89

Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation. Liver Transpl (2008) 0.88

Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies. J Gastrointest Surg (2012) 0.87

Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection. Int J Hepatol (2011) 0.86

Evaluation of standard liver volume formulae for Chinese adults. World J Gastroenterol (2009) 0.83

Treatment of HCC: the role of liver resection in the era of transplantation. Transplant Proc (2001) 0.80

Outcomes of loco-regional therapy for down-staging of hepatocellular carcinoma prior to liver transplantation. Hepatobiliary Pancreat Dis Int (2011) 0.79

Transplantation for liver tumors. Semin Oncol (2005) 0.79

Post-transplant lymphoproliferative disorders in liver transplanted patients: a single-centre experience. Anticancer Res (2010) 0.77

Transplantation versus resection for hepatocellular carcinoma in the mild cirrhotic: framing the debate. J Gastrointest Surg (2009) 0.76

Articles by these authors

Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int (2007) 1.56

Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2015) 1.39

miR-133b, a muscle-specific microRNA, is a novel prognostic marker that participates in the progression of human colorectal cancer via regulation of CXCR4 expression. Mol Cancer (2013) 1.15

Prognostic impact of telomere maintenance gene polymorphisms in hepatocellular carcinoma patients: some issues need to be clarified. Hepatology (2014) 1.08

Health-related quality of life of 256 recipients after liver transplantation. World J Gastroenterol (2012) 1.07

Is absolute lymphocyte count a good prognostic predictor in recurrence of hepatocellular carcinoma after liver transplantation? Transplantation (2014) 1.07

Methodological remarks concerning the recent meta-analysis on CYP1A1 polymorphisms-smoking interaction and hepatocellular carcinoma risk. Mol Biol Rep (2012) 1.06

Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma. World J Gastroenterol (2013) 1.02

Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. J Surg Res (2008) 0.99

Analysis of infections in the first 3-month after living donor liver transplantation. World J Gastroenterol (2012) 0.99

Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients. World J Gastroenterol (2007) 0.94

Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma. Cancer Lett (2008) 0.93

Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients: a meta-analysis. Eur J Gastroenterol Hepatol (2013) 0.92

Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int (2010) 0.91

Differentially expressed microRNAs in the serum of cervical squamous cell carcinoma patients before and after surgery. J Hematol Oncol (2014) 0.90

Donor right hepatectomy in living donor liver transplantation: report of 143 cases. Hepatogastroenterology (2011) 0.90

Higher tacrolimus blood concentration is related to hyperlipidemia in living donor liver transplantation recipients. Dig Dis Sci (2011) 0.89

Unsuccessful treatment of four patients with acute graft-vs-host disease after liver transplantation. World J Gastroenterol (2012) 0.89

Oxidative DNA damage in peripheral leukocytes and its association with expression and polymorphisms of hOGG1: a study of adolescents in a high risk region for hepatocellular carcinoma in China. World J Gastroenterol (2003) 0.88

Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol (2009) 0.88

Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol (2008) 0.87

Improved two-cuff technique for orthotopic liver transplantation in rat. Hepatobiliary Pancreat Dis Int (2004) 0.87

Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation. Hepatobiliary Pancreat Dis Int (2004) 0.87

Genetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study. Int J Cancer (2012) 0.86

Prolongation of liver allograft survival by dendritic cells modified with NF-kappaB decoy oligodeoxynucleotides. World J Gastroenterol (2004) 0.86

Orthotopic liver transplantation for patients with Caroli's disease. Hepatobiliary Pancreat Dis Int (2008) 0.86

Hemihepatic versus total hepatic inflow occlusion during hepatectomy: a systematic review and meta-analysis. World J Gastroenterol (2011) 0.86

Staging of hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int (2003) 0.85

Preoperative predictors of portal vein thrombosis after splenectomy with periesophagogastric devascularization. World J Gastroenterol (2012) 0.84

 Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Ann Hepatol (2012) 0.84

Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis. World J Gastroenterol (2011) 0.84

Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2011) 0.84

Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol (2003) 0.84

Analysis of CD8+CD28- T-suppressor cells in living donor liver transplant recipients. Hepatobiliary Pancreat Dis Int (2009) 0.83

Evaluation of standard liver volume formulae for Chinese adults. World J Gastroenterol (2009) 0.83

Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology (2012) 0.83

Caudate lobectomy by the third porta hepatis anatomical method: a study of 16 cases. Hepatobiliary Pancreat Dis Int (2006) 0.83

Highly sensitive enumeration of circulating tumor cells in lung cancer patients using a size-based filtration microfluidic chip. Biosens Bioelectron (2013) 0.83

Risk factors for early recurrence of HBV-related hepatocellular carcinoma meeting milan criteria after curative resection. Asian Pac J Cancer Prev (2013) 0.83

Graft size alone should not affect donors selection and be used to predict the prognosis of recipients after living donor liver transplantation. Hepatogastroenterology (2012) 0.82

Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis. World J Gastroenterol (1999) 0.82

Liver transplantation for patients with hepatolithiasis. Hepatobiliary Pancreat Dis Int (2005) 0.82

p73 G4C14-A4T14 polymorphism and cancer risk: a meta-analysis based on 27 case-control studies. Mutagenesis (2011) 0.82

Randomized comparison of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infection. Asian J Surg (2004) 0.82

A successful pregnancy following liver transplantation. Hepatobiliary Pancreat Dis Int (2007) 0.82

Protective effect of nitric oxide induced by ischemic preconditioning on reperfusion injury of rat liver graft. World J Gastroenterol (2004) 0.82

Delayed internal pancreatic fistula with pancreatic pleural effusion postsplenectomy. World J Gastroenterol (2010) 0.81

Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells. Hepatobiliary Pancreat Dis Int (2006) 0.81

Evaluation of oxidative stress in a group of adolescents exposed to a high level of aflatoxin B1--a multi-center and multi-biomarker study. Carcinogenesis (2007) 0.81

Safety of living donor liver transplantation using older donors. J Surg Res (2012) 0.81

Microsurgical reconstruction of hepatic artery in A-A LDLT: 124 consecutive cases without HAT. World J Gastroenterol (2010) 0.81

Treatment of hepatic venous outflow stenosis after living donor liver transplantation by insertion of an expandable metallic stent. Hepatobiliary Pancreat Dis Int (2009) 0.81

Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. World J Gastroenterol (2012) 0.80

Dynamic alteration of HBV markers on active HBV replicative recipients after liver transplantation: a preliminary report. Hepatobiliary Pancreat Dis Int (2003) 0.80

Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma. Hepatogastroenterology (2008) 0.80

Measures for increasing the safety of donors in living donor liver transplantation using right lobe grafts. Hepatobiliary Pancreat Dis Int (2007) 0.80

Hepatic venous outflow reconstruction in right lobe graft without middle hepatic vein. Hepatol Res (2007) 0.80

Transdiaphragmatic exposure for direct atrioatrial anastomosis in liver transplantation. Chin Med J (Engl) (2010) 0.80

Is correction for protein concentration appropriate for protein adduct dosimetry? Hypothesis and clues from an aflatoxin B1-exposed population. Cancer Sci (2007) 0.80

Risks faced by donors of right lobe for living donor liver transplantation. Hepatobiliary Pancreat Dis Int (2009) 0.80

Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol (2010) 0.80

Problems in adult living donor liver transplantation using the right hepatic lobe. Hepatobiliary Pancreat Dis Int (2006) 0.79

Donor safety and remnant liver volume in living donor liver transplantation. World J Gastroenterol (2012) 0.79

Zinc finger protein A20 promotes regeneration of small-for-size liver allograft and suppresses rejection and results in a longer survival in recipient rats. J Surg Res (2008) 0.79

Hepatic venous outflow reconstruction in adult right lobe living donor liver transplantation without middle hepatic vein. Chin Med J (Engl) (2007) 0.79

Overexpression of TIMP-1 mediated by recombinant adenovirus in hepatocellular carcinoma cells inhibits proliferation and invasion in vitro. Hepatobiliary Pancreat Dis Int (2006) 0.79

Interleukin-10-1082G/A polymorphism and acute liver graft rejection: a meta-analysis. World J Gastroenterol (2012) 0.79

Alternatives to albumin administration in hepatocellular carcinoma patients undergoing hepatectomy: an open, randomized clinical trial of efficacy and safety. Chin Med J (Engl) (2011) 0.79

Retrospective analysis of prognostic factors after liver transplantation for intrahepatic cholangiocarcinoma in China: a single-center experience. Hepatogastroenterology (2011) 0.79

Evaluation outcomes of donors in living donor liver transplantation: a single-center analysis of 132 donors. Hepatobiliary Pancreat Dis Int (2011) 0.79

Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. World J Gastroenterol (2009) 0.79

Improved early diagnosis of cystadenocarcinoma of the pancreas. Hepatobiliary Pancreat Dis Int (2007) 0.79

Cavoportal hemitransposition in liver transplantation: a new technique. Hepatobiliary Pancreat Dis Int (2003) 0.79

Factors associated with early mortality after living-donor liver transplant. Exp Clin Transplant (2014) 0.78

Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC. Hepatobiliary Pancreat Dis Int (2016) 0.78

Prophylaxis of chronic kidney disease after liver transplantation--experience from west China. World J Gastroenterol (2012) 0.78

Retrospective study of steroid therapy for patients with autoimmune pancreatitis in a Chinese population. World J Gastroenterol (2013) 0.78

Causes of mortality after liver transplantation: a single center experience in mainland china. Hepatogastroenterology (2012) 0.78

Quality of life and psychological outcome of donors after living donor liver transplantation. World J Gastroenterol (2012) 0.78

IFN-γ+874 A/T polymorphism and cancer risk: an updated analysis based on 32 case-control studies. Cytokine (2011) 0.78

Posttraumatic stress disorder after liver transplantation. Hepatobiliary Pancreat Dis Int (2012) 0.78

Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J Gastrointest Surg (2014) 0.78

Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol (2009) 0.78